Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1992 3
1993 1
1994 1
1996 2
1997 1
1998 2
2000 1
2001 1
2002 2
2004 1
2006 2
2008 1
2009 1
2010 3
2011 3
2012 3
2013 1
2014 1
2016 2
2017 2
2019 1
2020 2
2021 4
2022 4
2023 8
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis.
Foley JF, Defer G, Ryerson LZ, Cohen JA, Arnold DL, Butzkueven H, Cutter GR, Giovannoni G, Killestein J, Wiendl H, Li K, Dsilva L, Toukam M, Ferber K, Sohn J, Engelman H, Lasky T. Foley JF, et al. Among authors: lasky t. Neurol Neuroimmunol Neuroinflamm. 2024 Dec;11(6):e200321. doi: 10.1212/NXI.0000000000200321. Epub 2024 Oct 11. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39393045 Free PMC article. Clinical Trial.
Real world data (RWD) in pediatrics.
Lasky T, Chakravarty A. Lasky T, et al. J Biopharm Stat. 2023 Nov 2;33(6):875-880. doi: 10.1080/10543406.2022.2152834. Epub 2022 Dec 15. J Biopharm Stat. 2023. PMID: 36519238
Resilience in rural health system.
Lasky T, Samanta D, Sebastian W, Calderwood L. Lasky T, et al. Clin Teach. 2024 Aug;21(4):e13726. doi: 10.1111/tct.13726. Epub 2024 Jan 28. Clin Teach. 2024. PMID: 38282472
Current needs in pediatric pharmacoepidemiology.
Lasky T, Artaman A, Czaja AS, Maruti SS, Osokogu OU, Verhamme KM, Sobel RE. Lasky T, et al. Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):738-42. doi: 10.1002/pds.3985. Epub 2016 Feb 22. Pharmacoepidemiol Drug Saf. 2016. PMID: 26910571
Categorization of COVID-19 severity to determine mortality risk.
Garry EM, Weckstein AR, Quinto K, Bradley MC, Lasky T, Chakravarty A, Leonard S, Vititoe SE, Easthausen IJ, Rassen JA, Gatto NM. Garry EM, et al. Among authors: lasky t. Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):721-728. doi: 10.1002/pds.5436. Epub 2022 May 9. Pharmacoepidemiol Drug Saf. 2022. PMID: 35373865 Free PMC article.
Selection of cases and controls.
Lasky T, Stolley PD. Lasky T, et al. Epidemiol Rev. 1994;16(1):6-17. doi: 10.1093/oxfordjournals.epirev.a036145. Epidemiol Rev. 1994. PMID: 7925728 Review. No abstract available.
Criteria supporting the study of drugs in the newborn.
Ward RM, Benitz WE, Benjamin DK Jr, Blackmon L, Giacoia GP, Hudak M, Lasky T, Rodriguez W, Selen A. Ward RM, et al. Among authors: lasky t. Clin Ther. 2006 Sep;28(9):1385-98. doi: 10.1016/j.clinthera.2006.09.007. Clin Ther. 2006. PMID: 17062311 Review.
54 results